145 related articles for article (PubMed ID: 14571765)
1. Iron depletion and response to interferon in chronic hepatitis C.
Carlo C; Daniela P; Giancarlo C
Hepatogastroenterology; 2003; 50(53):1467-71. PubMed ID: 14571765
[TBL] [Abstract][Full Text] [Related]
2. [Effect of iron depletion on long-term response to interferon in patients with chronic hepatitis C with increased plasma iron without accumulation of liver iron].
Cagnoni C; Corsini F; Pancotti D; Carrara G
Ann Ital Med Int; 2000; 15(2):132-8. PubMed ID: 10920503
[TBL] [Abstract][Full Text] [Related]
3. [The effect of iron depletion on the response to interferon treatment in patients with chronic hepatitis C. Pilot study].
Ortiz V; Olaso V; López Viedma B; Córdoba J; Molina JM; Lainez B; Pastor M; Berenguer J
Gastroenterol Hepatol; 1999 Mar; 22(3):122-6. PubMed ID: 10228321
[TBL] [Abstract][Full Text] [Related]
4. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
Girelli CM; Mirata C; Casiraghi A
Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
[TBL] [Abstract][Full Text] [Related]
5. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
Alexander J; Tung BY; Croghan A; Kowdley KV
Liver Int; 2007 Mar; 27(2):268-73. PubMed ID: 17311623
[TBL] [Abstract][Full Text] [Related]
6. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
[TBL] [Abstract][Full Text] [Related]
7. Additional effect of low iron diet on iron reduction therapy by phlebotomy for chronic hepatitis C.
Kimura F; Hayashi H; Yano M; Yoshioka K; Matsumura T; Fukuda T; Shigeto N; Yamahara S; Koushi F; Mishima Y; Yoshino T; Tanimoto M; Kimura I
Hepatogastroenterology; 2005; 52(62):563-6. PubMed ID: 15816478
[TBL] [Abstract][Full Text] [Related]
8. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S
Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015
[TBL] [Abstract][Full Text] [Related]
9. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C.
Yano M; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Shiono Y; Arao M; Ukai K; Ito H; Watanabe K; Yoshioka K
Am J Gastroenterol; 2002 Jan; 97(1):133-7. PubMed ID: 11808937
[TBL] [Abstract][Full Text] [Related]
10. The effect of interferon and desferrioxamine on serum ferritin and hepatic iron concentrations in chronic hepatitis B.
Bayraktar Y; Saglam F; Temizer A; Uzunalimodlu B; van Thiel DH
Hepatogastroenterology; 1998; 45(24):2322-7. PubMed ID: 9951916
[TBL] [Abstract][Full Text] [Related]
11. A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.
Yano M; Hayashi H; Yoshioka K; Kohgo Y; Saito H; Niitsu Y; Kato J; Iino S; Yotsuyanagi H; Kobayashi Y; Kawamura K; Kakumu S; Kaito M; Ikoma J; Wakusawa S; Okanoue T; Sumida Y; Kimura F; Kajiwara E; Sata M; Ogata K
J Gastroenterol; 2004 Jun; 39(6):570-4. PubMed ID: 15235875
[TBL] [Abstract][Full Text] [Related]
12. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
Di Bisceglie AM; Bonkovsky HL; Chopra S; Flamm S; Reddy RK; Grace N; Killenberg P; Hunt C; Tamburro C; Tavill AS; Ferguson R; Krawitt E; Banner B; Bacon BR
Hepatology; 2000 Jul; 32(1):135-8. PubMed ID: 10869301
[TBL] [Abstract][Full Text] [Related]
13. Assessment of iron metabolism in children with chronic hepatitis B -- prognostic factor in interferon alpha therapy.
Chrobot A; Chrobot AM; Szaflarska-Szczepanik A
Med Sci Monit; 2002 Apr; 8(4):CR269-73. PubMed ID: 11951069
[TBL] [Abstract][Full Text] [Related]
14. Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients.
Iwasa M; Kaito M; Ikoma J; Kobayashi Y; Tanaka Y; Higuchi K; Takeuchi K; Iwata K; Watanabe S; Adachi Y
Hepatogastroenterology; 2002; 49(44):529-31. PubMed ID: 11995488
[TBL] [Abstract][Full Text] [Related]
15. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of iron status in patients with chronic hepatitis C.
Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
18. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
[TBL] [Abstract][Full Text] [Related]
19. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
20. Disturbances of iron metabolism in chronic liver diseases.
Sikorska K; Stalke P; Lakomy EA; Michalska Z; Witczak-Malinowska K; Stolarczyk J
Med Sci Monit; 2003 Aug; 9 Suppl 3():64-7. PubMed ID: 15156616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
